Finally, analysis of human CRC biopsies revealed higher expression of ALDH1 and CD44 in tumors expressing p53 missense mutations compared with wild-type p53 or p53 indel mutation-expressing tumors, which further emphasizes the importance of our observations for human CRC patients. This evidence concerns the gene CD44 and colorectal carcinoma.